U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022107

Expand all

TEKTURNA HCT (ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE)
EQ 150MG BASE;12.5MG
Marketing Status: Discontinued
Active Ingredient: ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: TEKTURNA HCT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE;12.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022107
Product Number: 001
Approval Date: Jan 18, 2008
Applicant Holder Full Name: NODEN PHARMA DAC
Marketing Status:  Discontinued
Patent and Exclusivity Information
TEKTURNA HCT (ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE)
EQ 150MG BASE;25MG
Marketing Status: Discontinued
Active Ingredient: ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: TEKTURNA HCT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE;25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022107
Product Number: 002
Approval Date: Jan 18, 2008
Applicant Holder Full Name: NODEN PHARMA DAC
Marketing Status:  Discontinued
Patent and Exclusivity Information
TEKTURNA HCT (ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE)
EQ 300MG BASE;12.5MG
Marketing Status: Discontinued
Active Ingredient: ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: TEKTURNA HCT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;12.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022107
Product Number: 003
Approval Date: Jan 18, 2008
Applicant Holder Full Name: NODEN PHARMA DAC
Marketing Status:  Discontinued
Patent and Exclusivity Information
TEKTURNA HCT (ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE)
EQ 300MG BASE;25MG
Marketing Status: Discontinued
Active Ingredient: ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: TEKTURNA HCT
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE;25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022107
Product Number: 004
Approval Date: Jan 18, 2008
Applicant Holder Full Name: NODEN PHARMA DAC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top